MENU
CGEM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cullinan Therapeutics (CGEM) Earnings Date & Reports

Cullinan Therapeutics Inc is a biopharmaceutical company... Show more

A.I. Advisor
published Earnings

CGEM is expected to report earnings to fall 20.10% to -85 cents per share on November 06

Cullinan Therapeutics CGEM Stock Earnings Reports
Q3'25
Est.
$-0.85
Q2'25
Missed
by $0.25
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.10
The last earnings report on August 07 showed earnings per share of -107 cents, missing the estimate of -81 cents. With 41.30K shares outstanding, the current market capitalization sits at 430.95M.
View a ticker or compare two or three
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEM showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Main Street
Phone
+1 617 410-4650
Employees
85
Web
https://www.cullinanoncology.com